In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1064-1072

  Bel, N ^a   Artigas, F ^a,b  

^a CSIC   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; CARRIER PROTEIN; CLONIDINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CARRIER PROTEINS; CEREBRAL CORTEX; CITALOPRAM; CLONIDINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; NERVE TISSUE PROTEINS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS;

EID: 0030426839     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. ADELL, A. AND ARTIGAS, F.: Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 343: 237-244, 1991.
2. ADELL, A., CARCELLER A. AND ARTIGAS F: In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60: 1673-1681, 1993.
3. ANDERSON, I. M. AND TOMENSON, B. M.: The efficacy of selective serotonin re-uptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants. J. Psychopharmacol. 8: 238-249, 1994.
4. ANSSEAU, M., VON FRENCKELL, R., MERTENS, C., DE WILDE, J., BOTTE, L., DEVOITILLE, J. M., EVRARD, J. L., DE NAYER, A., DARIMONT, P., DEJAIFFE, G., MIREL, J., MEURICE, E., PARENT, M., COUZINIER, J. P., DEMAREZ, J. P., AND SERRE, C.: Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology (Berl.) 98: 163-168, 1989.
5. ARTIGAS, F.: 5-HT and antidepressants: New views from microdialysis studies. Trends Pharmacol. Sci. 14: 262, 1993.
6. ASTON-JONES, G., SHIPLEY, M. T., CHOUVET, G., ENNIS, M., VAN BOCKSTAELE, V., PIERIBONE, V., SHIEKHATTER, R., AKAOKA, H., DROLET, G., ASTIER, P., CHARLÉTY, P., VALENTINO, R. J. AND WILLIAMS, J. T.: Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. Prog. Brain Res. 88: 47-76, 1991.
7. BARABAN, J. M. AND AGHAJANIAN, G. K.: Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19: 355-363, 1980.
8. BARKAI, A. I., SUCKOW, R. F. AND COOPER, T. B.: Imipramine and its metabolites: Relationship to cerebral catecholamines in rats in vivo. J. Pharmacol. Exp. Ther. 230: 330-335, 1984.
9. BAUMANN, P. AND ROCHAT, B.: Comparative pharmacokinetics of selective serotonin reuptake inhibitors: A look behind the mirror. Int. Clin. Psychopharmacol. 10: Suppl. 1, 15-21, 1995.
10. BEL, N. AND ARTIGAS, F.: Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur. J. Pharmacol. 229: 101-103, 1992.
11. BEL, N. AND ARTIGAS, F.: Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15: 243-245, 1993.
12. BLIER, P. AND DE MONTIGNY, C.: Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15: 220-226, 1994.
13. BRILEY, M. AND MORET, C.: Neurobiological mechanisms involved in antidepressant therapies. Clin. Neuropharmacol. 16: 387-400, 1993.
14. 2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638: 311-324, 1994.
15. CACCIA, S., CAPPI, M., FRASCASSO, C. AND GARATTINI, S.: Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100: 509-514, 1990.
16. CARBONI, E. AND DI CHIARA, G.: Serotonin release estimated by transcortical dialysis in freely-moving animals. Neuroscience 32: 637-645, 1989.
17. CARLSSON, A., CORRODI, H., FUXE, K. AND HÖKFELT, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur. J. Pharmacol. 5: 357-366, 1969a.
18. CARLSSON, A., CORRODI, H., FUXE, K. AND HÖKFELT, T.: Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4-alpha-dimethyl-meta-tyramine. Eur. J. Pharmacol. 5: 367-373, 1969b.
19. CASANOVAS, J. M. AND ARTIGAS, F: Differential effects of ipsapirone on 5-HT release in the dorsal and median raphe neuronal pathways. J. Neurochem., in press, 1996.
20. CELADA, P. AND ARTIGAS, F.: Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 347: 583-590, 1993a.
21. CELADA, P., AND ARTIGAS, F.: Interaction between noradrenaline and serotonin: Unchanged somatodendritic release of serotonin after noradrenergic agonists. Eur. J. Neurosci. 6: (Suppl.) 168, 1993b.
22. CELADA, P., BEL, N. AND ARTIGAS, F.: The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rat. J. Neural. Transm. (Suppl.) 41: 357-363, 1994.
23. 3H]paroxetine. Neuroscience 27: 473-496, 1988.
24. CUSACK, B., NELSON, A. AND RICHELSON, E.: Binding of antidepressants to human brain receptors: Focus on newer generation compounds. Psychopharmacology 114: 559-565, 1994.
25. DANIEL, W., ADAMUS, A., MELZACKA, M., SZYMURA, J. AND VETULANI, J.: Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn-Schmiedeberg's Arch. Pharmacol. 317: 209-213, 1981.
26. DANISH UNIVERSITY ANTIDEPRESSANT GROUP: Citalopram: Clinical effect profile in comparison with domipramine. A controlled multicenter study. Psychopharmacology 90: 131-138, 1986.
27. DANISH UNIVERSITY ANTIDEPRESSANT GROUP: Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than domipramine in a controlled multicenter study. J. Affective Disord. 18: 289-299, 1990.
28. FERRER, A. AND ARTIGAS, F.: Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur. J. Pharmacol. 263: 227-234, 1994.
29. FERRÉ, S., CORTÉS, R. AND ARTIGAS, F.: Dopaminergic regulation of the serotonergic raphe-striatal pathway: Microdialysis studies in freely moving rats. J. Neurosci. 14: 4839-4846, 1994.
30. FULLER, R. W.: Minireview: Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55: 163-167, 1994.
31. 3H)imipramine binding sites in the brain of the rat: Relationship to ascending 5-hydroxytryptamine neuron systems. Proc. Natl. Acad. Sci. U.S.A. 80: 3836-3840, 1983.
32. GOODNOUGH, D. B. AND BAKER, G. B.: 5-Hydroxytryptamine(2) and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62: 2262-2268, 1994.
33. HALLIDAY, G., HARDING, A. AND PAXINOS, G.: Serotonin and tachykinin systems. In The Rat Nervous System, 2nd ed., ed. by G. Paxinos, pp. 929-974, Academic Press, San Diego, 1995.
34. 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4: 131-144, 1991.
35. 3H]imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252: 410-418, 1990.
36. INVERNIZZI, R., BELLI, S. AND SAMANIN, R.: Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584: 321-326, 1992.
37. 1A receptors. Eur. J. Pharmacol. 260: 243-246, 1994.
38. JAVAID, J. I., PEREL, J. M. AND DAVIS, J. M.: Inhibition of biogenic amines uptake by imipramine, desipramine, 2-OH-imipramine and 2-OH-desipramine in rat brain. Life Sci. 24: 21-28, 1979.
39. KIHARA, T. AND IKEDA, M.: Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor on extracellular monoamine levels in rat frontal cortex. J. Pharmacol. Exp. Ther. 272: 177-183, 1995.
40. KREISS, D. AND LUCKI, I.: Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274: 866-876, 1995.
41. LESCH, K. P., AULAKH, C. S., WOLOZIN, B. L., TOLLIVER, T. J., HILL, J. L. AND MURPHY, D. L.: Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol. Brain Res. 17: 31-35, 1993.
42. L'HEUREUX, R., DENNIS, T., CURET, O. AND SCATTON, B.: Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: Effects of drugs affecting noradrenergic transmission. J. Neurochem. 46: 1784-1801, 1986.
43. MALAGIÉ, I., TRILLAT, A. C., JACQUOT, C. AND GARDIER, A. M.: Effects of actue fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study. Eur. J. Pharmacol. 286: 213-217, 1996.
44. MONGEAU, R., BLIER, P. AND DE MONTIGNY, C.: In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha-2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 347: 266-272, 1993.
45. MONGEAU, R., DE MONTIGNY, C. AND BLIER, P.: Electrophysiologic evidence for desensitization of alpha(2)-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10: 41-51, 1994.
46. NELSON, J. C., MAZURE, C. M., BOWERS, M. B. AND JATLOW, P. I.: A preliminary open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch. Gen. Psychiatry 48: 303-307, 1991.
47. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
48. 1 receptors. Brain Res. 346: 205-230, 1985.
49. PERRY, K. W. AND FULLER, R. W.: Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50: 1683-1690, 1992.
50. PINEYRO, G., BLIER, P., DENNIS, T. AND DE MONTIGNY, C.: Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci. 14: 3036-3047, 1994.
51. RICHELSON, E. AND NELSON, A.: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J. Pharmacol. Exp. Ther. 230: 94-102, 1984.
52. RICHELSON, E. AND PFENNING, M.: Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104: 277-286, 1984.
53. RIGDON, G. C. AND WANG, C. M.: Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev. Res. 22: 135-140, 1991.
54. o proteins in dorsal raphe nucleus. Eur. J. Pharmacol. 265: 103-106, 1994.
55. RUDORFER, M. V. AND POTTER, W. Z.: Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the "newer" versus the "older" drugs. Drugs 37: 713-738, 1989.
56. RUTTER, J. J. AND AUERBACH, S. B.: Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265: 1319-1324, 1993.
57. RUTTER, J. J., GUNDLAH, C. AND AUERBACH, S. B.: Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171: 183-186, 1994.
58. 3H-Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neurosci. 12: 1977-1999, 1992.
59. SCHILDKRAUT, J. J., WINOKUR, A. AND APPLEGATE, C. W.: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science (Wash. DC) 168: 867-869, 1970.
60. SCHWEIZER, E., FEIGHNER, J., MANDOS, L. A. AND RICKELS, K.: Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J. Clin. Psychiatry 55: 104-108, 1994.
61. SCHWEIZER, E., WEISE, C., CLARY, C., FOX, I. AND RICKELS, K.: Placebo-controlled trial of venlafaxine for the treatment of major depression. J. Clin. Psychopharmacol. 11: 233-236, 1991.
62. SCUVÉE-MOREAU, J. AND DRESSE, A.: Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur. J. Pharmacol. 57: 219-225, 1979.
63. SEGAL, M.: Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J. Physiol. (Lond.) 286: 401-415, 1979.
64. SERRE, C., CLERC, G., ESCANDE, M., FELINE, A., GINESTET, D., TIGNOL, J. AND VAN AMERONGEN, P.: An early clinical trial of midalcipran. 1. Phenyl-1-diethyl aminocarbonyl-2-aminomethyl cyclopropane (Z) hidrochloride, a potential fourth generation antidepressant. Curr. Ther. Res. 39: 156-164, 1986.
65. SHARP, T., BRAMWELL, S. R., CLARK, D. AND GRAHAME-SMITH, D. G.: In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53: 234-240, 1989.
66. SOTELO, C., CHOLLEY, B., EL MESTIKAWY, S., GOZLAN, H. AND HAMON, M.: Direct immunohistochemical evidence of the existence of 5-HT autoreceptors on serotonergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2: 1144-1154, 1990.
67. STARKE, K. AND MONTEL, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12: 1073-1080, 1973.
68. STEINBUSH, H. W. M.: Serotonin-immunoreactive neurons and their projections in the CNS. In Handbook of Chemical Neuroanatomy, Vol. 3, Part II, Classical Transmitters and Transmitter Receptors in the CNS, ed. by A. Björklund, T. Hökfelt and M. J. Kuhar, pp. 68-125, Elsevier, Amsterdam, 1984.
69. TANDA, G., CARBONI, E., FRAU, R. AND DI CHIARA, G.: Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential? Psychopharmacology 115: 285-288, 1994.
70. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 345: 137-143, 1992.
71. VANDERMAELEN, C. P. AND AGHAJANIAN, G. K.: Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellulary and intracellulary in rat brain slices. Brain Res. 289: 109-119, 1983.
72. WONG, D. T., BYMASTER, F. P., MAYLE, D. A., REID, L. R., KRUSHINSKI, J. H. AND ROBERTSON, D. W.: LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8: 23-33, 1993.
73. WOZNIAK, K., PERT, A. AND LINNOILA, M.: Alterations in raphe and frontal cortex serotonin overflow following focal and systemic administration of serotonin. Soc. Neurosci. Abs. 18: 1525, 1992.